Posted on September 22nd, 2014
Gregory T. Mayes joined Advaxis in October 2013 as Executive Vice President and Chief Operating Officer.
Company OverviewAdvaxis is a clinical-stage biotechnology company developing the next generation of cancer immunotherapies. Advaxis immunotherapies are based on a novel platform technology using live, attenuated bacteria that are bio-engineered to secrete antigen/adjuvant fusion protein(s) designed to redirect the powerful immune response all human beings have to the bacterium to the cancer itself. ADXS-HPV is being evaluated in Phase 1 and Phase 2 clinical trials for HPV-associated diseases including invasive cervical cancer, HPV-associated head and neck cancer, and anal cancer. Over fifteen (15) distinct constructs are in various stages of development, developed directly by the Company and through strategic collaborations with recognized centers of excellence. ... Learn More »
At 10:29 p.m. this evening it will officially be fall in Princeton, NJ, the home of Advaxis. The formal passage of summe...Read More »
Posted on September 18th, 2014
Management is acutely aware of the depreciation in the value of our equity over the last several weeks. We have undertak...Read More »
Posted on September 16th, 2014
Over the weekend, the New York Times published a front-page article entitled; “Brain Trauma to Affect One in Three...Read More »
Posted on September 15th, 2014
It is my pleasure to introduce you to Targeted Medical Pharma (TRGM) with my first blog in a series of informative discu...Read More »
Posted on September 10th, 2014
Are pandemic viral pathogens establishing a global foothold? At present, the deadliest Ebola virus outbreak in history...Read More »
Reveal Insights About Your Company and Industry to Shareholders.
The Chairman's Blog is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. The Chairman's Blog enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. Learn More »